Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAIANO: Residual Platelet Activity in PAD
NCT01627431Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Jul 2012
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, clopidogrel in Peripheral Arterial Disease (PAD), sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
aspirinclopidogrel
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT01627431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627431.